James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $542.94 ($5.5M) on 2026-06-11, disclosed to the SEC on 2026-06-12.
Scheduled sale ($5.5M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $542.94 | 46 | $25K | 0.5% |
| 2 | $544.37 | 154 | $84K | 1.5% |
| 3 | $545.14 | 442 | $241K | 4.4% |
| 4 | $547.08 | 134 | $73K | 1.3% |
| 5 | $548.02 | 2,037 | $1.1M | 20.3% |
| 6 | $549.11 | 1,974 |
| $1.1M |
| 19.7% |
| 7 | $550.04 | 3,333 | $1.8M | 33.4% |
| 8 | $551.10 | 1,560 | $860K | 15.7% |
| 9 | $551.83 | 320 | $177K | 3.2% |
| Total | $549.29 avg | 10,000 | $5.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-05 | $5.5M | — | Filing → |